Cargando…
The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
Deoxycholic Acid (DCA), which is an FDA-approved compound for the reduction of submental fat, has evolved through an unanticipated and surprising sequence of events. Initially, it was used as a solvent for Phosphatidylcholine (PDC), which was thought to promote lipolysis, but it was later proven to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988282/ https://www.ncbi.nlm.nih.gov/pubmed/35399925 http://dx.doi.org/10.3389/fendo.2022.841889 |
_version_ | 1784682927275114496 |
---|---|
author | Muskat, Ahava Pirtle, Megan Kost, Yana McLellan, Beth N. Shinoda, Kosaku |
author_facet | Muskat, Ahava Pirtle, Megan Kost, Yana McLellan, Beth N. Shinoda, Kosaku |
author_sort | Muskat, Ahava |
collection | PubMed |
description | Deoxycholic Acid (DCA), which is an FDA-approved compound for the reduction of submental fat, has evolved through an unanticipated and surprising sequence of events. Initially, it was used as a solvent for Phosphatidylcholine (PDC), which was thought to promote lipolysis, but it was later proven to be the bioactive component of the formula and is currently widely used as Kybella. It has also been used off-label to treat other types of fat deposits like lipomas, HIV lipodystrophy, and excess orbital fat. Despite widespread clinical use, there has been no consensus clarifying the mechanisms of DCA and PDC alone or in combination. Furthermore, despite PDC’s removal from the FDA-approved formula, some studies do suggest it plays an important role in fat reduction. To provide some clarity, we conducted a PubMed search and reviewed 41 articles using a comprehensive list of terms in three main categories, using the AND operator: 1) Phosphatidylcholines 2) Deoxycholic Acid, and 3) Lipoma. We isolated articles that studied PDC, DCA, and a PDC/DCA compound using cell biology, molecular and genetic techniques. We divided relevant articles into those that studied these components using histologic techniques and those that utilized specific cell death and lipolysis measurement techniques. Most morphologic studies indicated that PDC/DCA, DCA, and PDC, all induce some type of cell death with accompanying inflammation and fibrosis. Most morphologic studies also suggest that PDC/DCA and DCA alone are non-selective for adipocytes. Biochemical studies describing PDC and DCA alone indicate that DCA acts as a detergent and rapidly induces necrosis while PDC induces TNF-α release, apoptosis, and subsequent enzymatic lipolysis after at least 24 hours. Additional papers have suggested a synergistic effect between the two compounds. Our review integrates the findings of this growing body of literature into a proposed mechanism of fat reduction and provides direction for further studies. |
format | Online Article Text |
id | pubmed-8988282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89882822022-04-08 The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation Muskat, Ahava Pirtle, Megan Kost, Yana McLellan, Beth N. Shinoda, Kosaku Front Endocrinol (Lausanne) Endocrinology Deoxycholic Acid (DCA), which is an FDA-approved compound for the reduction of submental fat, has evolved through an unanticipated and surprising sequence of events. Initially, it was used as a solvent for Phosphatidylcholine (PDC), which was thought to promote lipolysis, but it was later proven to be the bioactive component of the formula and is currently widely used as Kybella. It has also been used off-label to treat other types of fat deposits like lipomas, HIV lipodystrophy, and excess orbital fat. Despite widespread clinical use, there has been no consensus clarifying the mechanisms of DCA and PDC alone or in combination. Furthermore, despite PDC’s removal from the FDA-approved formula, some studies do suggest it plays an important role in fat reduction. To provide some clarity, we conducted a PubMed search and reviewed 41 articles using a comprehensive list of terms in three main categories, using the AND operator: 1) Phosphatidylcholines 2) Deoxycholic Acid, and 3) Lipoma. We isolated articles that studied PDC, DCA, and a PDC/DCA compound using cell biology, molecular and genetic techniques. We divided relevant articles into those that studied these components using histologic techniques and those that utilized specific cell death and lipolysis measurement techniques. Most morphologic studies indicated that PDC/DCA, DCA, and PDC, all induce some type of cell death with accompanying inflammation and fibrosis. Most morphologic studies also suggest that PDC/DCA and DCA alone are non-selective for adipocytes. Biochemical studies describing PDC and DCA alone indicate that DCA acts as a detergent and rapidly induces necrosis while PDC induces TNF-α release, apoptosis, and subsequent enzymatic lipolysis after at least 24 hours. Additional papers have suggested a synergistic effect between the two compounds. Our review integrates the findings of this growing body of literature into a proposed mechanism of fat reduction and provides direction for further studies. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8988282/ /pubmed/35399925 http://dx.doi.org/10.3389/fendo.2022.841889 Text en Copyright © 2022 Muskat, Pirtle, Kost, McLellan and Shinoda https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Muskat, Ahava Pirtle, Megan Kost, Yana McLellan, Beth N. Shinoda, Kosaku The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation |
title | The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation |
title_full | The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation |
title_fullStr | The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation |
title_full_unstemmed | The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation |
title_short | The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation |
title_sort | role of fat reducing agents on adipocyte death and adipose tissue inflammation |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988282/ https://www.ncbi.nlm.nih.gov/pubmed/35399925 http://dx.doi.org/10.3389/fendo.2022.841889 |
work_keys_str_mv | AT muskatahava theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT pirtlemegan theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT kostyana theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT mclellanbethn theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT shinodakosaku theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT muskatahava roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT pirtlemegan roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT kostyana roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT mclellanbethn roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation AT shinodakosaku roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation |